EE04036B1 - Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel - Google Patents

Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Info

Publication number: EE04036B1
Authority: EE; Estonia
Prior art keywords: alcohol; alcoholics; composition; craving; preventing
Prior art date: 1997-10-03

Application number

EEP200000235A

Other languages

English (en)

Estonian (et)

Inventor

Fassi Aldo

Cavazza Claudio

Original Assignee

Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-03

Filing date

1998-09-18

Publication date

2003-06-16

1998-09-18 Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

2001-06-15 Publication of EE200000235A publication Critical patent/EE200000235A/xx

2003-06-16 Publication of EE04036B1 publication Critical patent/EE04036B1/xx

Links

LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
208000007848 Alcoholism Diseases 0.000 title 2
206010001584 alcohol abuse Diseases 0.000 title 1
208000025746 alcohol use disease Diseases 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
235000019788 craving Nutrition 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
235000013402 health food Nutrition 0.000 abstract 1
239000002417 nutraceutical Substances 0.000 abstract 1
235000021436 nutraceutical agent Nutrition 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Addiction (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Detergent Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

EEP200000235A 1997-10-03 1998-09-18 Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel EE04036B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT97RM000594A IT1295408B1 (it)	1997-10-03	1997-10-03	Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (fr)	1997-10-03	1998-09-18	Compositions permettant de supprimer les symptomes de manque et les envies irrepressibles d'alcool chez les alcooliques, et d'eviter l'abus d'alcool chez les sujets sains

Publications (2)

Publication Number	Publication Date
EE200000235A EE200000235A (et)	2001-06-15
EE04036B1 true EE04036B1 (et)	2003-06-16

Family

ID=11405277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000235A EE04036B1 (et)	1997-10-03	1998-09-18	Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Country Status (27)

Country	Link
US (1)	US6255346B1 (fr)
EP (1)	EP1022960B1 (fr)
JP (1)	JP2001518484A (fr)
KR (2)	KR100560097B1 (fr)
CN (1)	CN1092939C (fr)
AT (1)	ATE220860T1 (fr)
AU (1)	AU730740B2 (fr)
BG (1)	BG64363B1 (fr)
BR (1)	BR9812604A (fr)
CA (1)	CA2305598C (fr)
CZ (1)	CZ291801B6 (fr)
DE (1)	DE69806788T2 (fr)
DK (1)	DK1022960T3 (fr)
EA (1)	EA002177B1 (fr)
EE (1)	EE04036B1 (fr)
ES (1)	ES2180200T3 (fr)
HU (1)	HUP0004336A3 (fr)
IS (1)	IS2234B (fr)
IT (1)	IT1295408B1 (fr)
MX (1)	MXPA00003232A (fr)
NO (1)	NO20001688L (fr)
NZ (1)	NZ503663A (fr)
PL (1)	PL189663B1 (fr)
PT (1)	PT1022960E (fr)
SK (1)	SK283384B6 (fr)
UA (1)	UA66807C2 (fr)
WO (1)	WO1999017623A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6090848A (en) *	1997-12-01	2000-07-18	Sigma-Tau Healthscience S.P.A.	Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) *	1999-07-28	2001-05-30	Sigma Tau Healthscience Spa	Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) *	2002-04-09	2003-10-09	Sigma Tau Healthscience Spa	Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
ITRM20020620A1 (it) *	2002-12-13	2004-06-14	Sigma Tau Ind Farmaceuti	Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US7776913B2 (en)	2002-12-13	2010-08-17	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Carnitines for treating or preventing disorders caused by andropause
RU2300376C2 (ru) *	2005-05-11	2007-06-10	МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово	Способ лечения при алкогольном делирии
CN101766672B (zh) *	2008-12-31	2012-10-10	克科	解酒醒酒组合物
CN101766715B (zh) *	2008-12-31	2012-08-29	克科	解酒醒酒组合物
CN101766716B (zh) *	2008-12-31	2012-08-29	克科	解酒醒酒组合物
CN101766717B (zh) *	2008-12-31	2012-10-10	克科	解酒醒酒组合物
CN101766637B (zh) *	2008-12-31	2012-08-29	克科	解酒醒酒组合物
CN101766635B (zh) *	2008-12-31	2012-10-10	克科	解酒醒酒组合物
CN106176756A (zh) *	2015-04-30	2016-12-07	刘力	包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) *	2020-04-14	2023-05-18	The Regents Of The University Of California	Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1245869B (it) *	1991-06-05	1994-10-25	Sigma Tau Ind Farmaceuti	Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) *	1995-07-26	1997-01-30	Hans Guenter Berner Gmbh	Nahrungsergänzungsmittel
EP0776604B1 (fr) *	1995-12-01	2002-01-23	Unilever N.V.	Petits pains croustillants chauffables au four à micro-ondes
ES2141463T3 (es) *	1996-03-04	2000-03-16	Sigma Tau Ind Farmaceuti	Medicamento conteniendo un derivado de la carnitina para el tratamiento de la arteriosclerosis obliterans.

1997
- 1997-10-03 IT IT97RM000594A patent/IT1295408B1/it active IP Right Grant
1998
- 1998-09-18 WO PCT/IT1998/000249 patent/WO1999017623A1/fr not_active Ceased
- 1998-09-18 US US09/509,652 patent/US6255346B1/en not_active Expired - Fee Related
- 1998-09-18 CA CA002305598A patent/CA2305598C/fr not_active Expired - Fee Related
- 1998-09-18 KR KR1020007003626A patent/KR100560097B1/ko not_active Expired - Fee Related
- 1998-09-18 ES ES98946703T patent/ES2180200T3/es not_active Expired - Lifetime
- 1998-09-18 BR BR9812604-0A patent/BR9812604A/pt not_active Application Discontinuation
- 1998-09-18 EA EA200000377A patent/EA002177B1/ru not_active IP Right Cessation
- 1998-09-18 NZ NZ503663A patent/NZ503663A/en unknown
- 1998-09-18 PT PT98946703T patent/PT1022960E/pt unknown
- 1998-09-18 KR KR10-2005-7014865A patent/KR100530368B1/ko not_active Expired - Fee Related
- 1998-09-18 HU HU0004336A patent/HUP0004336A3/hu unknown
- 1998-09-18 EP EP98946703A patent/EP1022960B1/fr not_active Expired - Lifetime
- 1998-09-18 EE EEP200000235A patent/EE04036B1/xx not_active IP Right Cessation
- 1998-09-18 CZ CZ20001207A patent/CZ291801B6/cs not_active IP Right Cessation
- 1998-09-18 UA UA2000041867A patent/UA66807C2/uk unknown
- 1998-09-18 AT AT98946703T patent/ATE220860T1/de not_active IP Right Cessation
- 1998-09-18 CN CN98810325A patent/CN1092939C/zh not_active Expired - Fee Related
- 1998-09-18 MX MXPA00003232A patent/MXPA00003232A/es active IP Right Grant
- 1998-09-18 AU AU93660/98A patent/AU730740B2/en not_active Ceased
- 1998-09-18 DK DK98946703T patent/DK1022960T3/da active
- 1998-09-18 JP JP2000514534A patent/JP2001518484A/ja active Pending
- 1998-09-18 PL PL98339621A patent/PL189663B1/pl not_active IP Right Cessation
- 1998-09-18 SK SK476-2000A patent/SK283384B6/sk unknown
- 1998-09-18 DE DE69806788T patent/DE69806788T2/de not_active Expired - Fee Related
2000
- 2000-03-24 IS IS5416A patent/IS2234B/is unknown
- 2000-03-30 BG BG104286A patent/BG64363B1/bg unknown
- 2000-03-31 NO NO20001688A patent/NO20001688L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK4762000A3 (en)	2000-10-09
MXPA00003232A (es)	2004-03-10
DE69806788T2 (de)	2003-04-03
KR100530368B1 (ko)	2005-11-22
HUP0004336A3 (en)	2001-07-30
EP1022960B1 (fr)	2002-07-24
CA2305598A1 (fr)	1999-04-15
CZ291801B6 (cs)	2003-05-14
IS5416A (is)	2000-03-24
EP1022960A1 (fr)	2000-08-02
PT1022960E (pt)	2002-12-31
HK1028714A1 (en)	2001-03-02
NO20001688L (no)	2000-06-02
EA200000377A1 (ru)	2000-10-30
BR9812604A (pt)	2000-08-01
IT1295408B1 (it)	1999-05-12
KR20010030928A (ko)	2001-04-16
CA2305598C (fr)	2007-11-20
DE69806788D1 (de)	2002-08-29
SK283384B6 (sk)	2003-06-03
DK1022960T3 (da)	2002-11-04
PL339621A1 (en)	2001-01-02
BG104286A (en)	2000-11-30
KR20050088499A (ko)	2005-09-06
NZ503663A (en)	2001-11-30
EA002177B1 (ru)	2002-02-28
AU730740B2 (en)	2001-03-15
CN1276704A (zh)	2000-12-13
US6255346B1 (en)	2001-07-03
HUP0004336A2 (hu)	2001-05-28
ATE220860T1 (de)	2002-08-15
EE200000235A (et)	2001-06-15
ITRM970594A1 (it)	1999-04-03
JP2001518484A (ja)	2001-10-16
ES2180200T3 (es)	2003-02-01
IS2234B (is)	2007-04-15
UA66807C2 (uk)	2004-06-15
AU9366098A (en)	1999-04-27
CN1092939C (zh)	2002-10-23
KR100560097B1 (ko)	2006-03-13
NO20001688D0 (no)	2000-03-31
BG64363B1 (bg)	2004-12-30
PL189663B1 (pl)	2005-09-30
CZ20001207A3 (cs)	2000-11-15
WO1999017623A1 (fr)	1999-04-15

Legal Events

Date	Code	Title	Description
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20080918

Publication	Publication Date	Title
EE04036B1 (et)	2003-06-16	Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel
WO2003013549A3 (fr)	2003-11-06	Formulation contenant de la (lyso-)phosphatidylserine, servant a prevenir et a traiter des etats de stress chez des homeothermes
BR9815302A (pt)	2000-10-17	Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
BR0008926A (pt)	2001-12-18	Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
WO2001062290A3 (fr)	2002-08-01	Methodes et compositions destinees a ameliorer la qualite du sommeil
BR9810547A (pt)	2000-08-15	Absorção de minerais pelas células intestinais
PT1337236E (pt)	2004-11-30	Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
CA2404387A1 (fr)	2001-10-11	Compositions de theanine favorisant le sommeil
WO2001026666A3 (fr)	2001-09-13	Composition pour la prevention et/ou le traitement de troubles circulatoires comprenant des derives de l-carnitine et des extraits de ginkgo biloba
DE69721497D1 (de)	2003-06-05	Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
EP1393738A4 (fr)	2004-11-17	Traitement antidiabetique
WO2003013564A3 (fr)	2003-04-10	Composition vegetale pour le traitement des difficultes respiratoires bronchiques
RU95119282A (ru)	1998-01-10	Композиция ингредиентов для лекарственного средства
CA2395530A1 (fr)	2001-06-28	Formate de calcium destine a etre utilise en tant que liant du phosphore et complement alimentaire
WO2002072035A3 (fr)	2003-02-13	Compositions anti-inflammatoires et procedes d'utilisation
BRPI0411436A (pt)	2006-07-18	composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
JP4706174B2 (ja)	2011-06-22	α−グルコシダーゼ阻害剤
Cerrato	2001	Ginseng doesn't improve one's mood
CA2325033A1 (fr)	2001-04-27	Utilisation du ribose pour traiter la fibromyalgie
Joseph	2021	A contemporary narrative review on Oral Submucous Fibrosis
EP0778027A3 (fr)	1998-04-01	Utilisation de silice pour la préparation de médicaments
ATE270095T1 (de)	2004-07-15	Arzneimittel zur anwendung im mund
ES2134865T3 (es)	1999-10-16	Uso de extracto de orujo de cerveza para la fabricacion de preparados de administracion oral.
Trivedi et al.	1994	Reversible Impairment of Glucose Tolerance in Patients with Endemic Fluorosis
Kim et al.	2000	Association between Nutrients Intake and Nutritional Status in Young Men